Abstract:
PURPOSE: A pharmaceutical composition containing S-adenosyl methionine is provided to relieve pain and side effects for cancer patients. CONSTITUTION: A pharmaceutical composition for cancer cells contains S-adenosyl methionine as an active ingredient. The S-adenosyl prevents an individual from 5-fluorouracil cytotoxic side effects of fluorouracil.